He coordinated an initiative of biological evaluation and repositioning of tenofovir fumarate for the treatment of COVID-19 and is conducting clinical studies with patients and applying metabolomics techniques. In 2005, he helped fund a Tech Park in Ribeirão Preto, elected among the top 20 in the world (UBI Global 2019 – 2020). PhD students and postdocs who worked in the group have created 6 companies with a strong impact on the local economy, with a large involvement with innovation programs.